Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin
โ Scribed by Y. Asahina; N. Izumi; N. Umeda; T. Hosokawa; K. Ueda; F. Doi; K. Tsuchiya; H. Nakanishi; K. Matsunaga; T. Kitamura; M. Kurosaki; M. Uchihara; M. Higaki; S. Miyake
- Book ID
- 108885957
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 599 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of
## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific realโtime PCR techniques are available commercially and ca